Collaborative Community against Coronovirus CIC (CCC CIC)

Not-for-profit preparing communities for viral epidemics.

covid-19 swab testing

A not-for-profit Community Interest Company (CIC) collaborative dedicated to ensuring that the worldwide community is better prepared for the epidemics caused by viruses.

They propose a new approach to emerging viruses, developing inhibitors of the viral RNA polymerase complex of coronaviruses, including COVID-19, to prevent researchers from beginning from a 'zero base' to combat a virus.

3C is led by a group of experts with backgrounds in antiviral drug discovery, in both pharma and biotech.

The CCC CIC journey so far: 

  • 2020: community interest company founded

Team

Dr Edward Littler

Dr. Edward Littler

Founder and CEO

Dr. Littler has 34 years of experience in anti-viral and microbial research, with additional experience in large pharma and biotech.

Ana Lemmo Charnalia

Business Manager

Centre for Digital Humanities

Ana supports SHAPE and social ventures, drawing on social investment, venture support and entrepreneurship experience. She managed the Health Social Innovators’ Programme and holds an MBA from Oxford.